Genomic data, read with CLARITY.

Prof. Dr. Tarık Salman is a Professor of Medical Oncology and Internal Medicine. After completing his medical education and internal medicine specialization, he completed subspecialty fellowship training in Medical Oncology at leading university medical faculties and tertiary oncology research centers. Committed early in his career to international standards and frontier cancer management strategies, he also completed an observership program at Memorial Sloan Kettering Cancer Center (MSKCC), building a robust foundation in clinical and translational research.

With over two decades of clinical, academic and leadership experience in oncology, Prof. Salman actively contributes to leading international scientific bodies, including the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO), as well as specialized societies in geriatric and Mediterranean oncology. His clinical and clinical-trial expertise spans complex solid tumors—most notably breast, lung and gastrointestinal malignancies—with a dedicated focus on targeted systemic therapies, novel immunotherapeutic modalities and the real-world value of multidisciplinary tumor boards.

At the forefront of oncology’s paradigm shift toward individualized care, Prof. Salman is a dedicated advocate for precision oncology, championing the seamless integration of comprehensive genomic profiling (CGP), multi-omics diagnostics, and biomarker-driven therapy selection into daily clinical workflows. As a seasoned clinical oncologist, academician, and healthcare opinion leader, he provides the crucial bedside-to-bench perspective needed to bridge high-throughput omics platforms, AI-driven pathology diagnostics, and novel pharmaceutical pipelines directly to patient-centered clinical efficacy, toxicity management, and cross-border innovation. With this goal in mind, he recently started utilizing his expertise in his Clinical Research Organization, Galenos CRO & Bioinformatics.